Express Scripts sees no let-up in drug pricing chatter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. NEST:IN
10. AA

Go back to Express Scripts sees no let-up in drug pricing chatter

Mizuho Securities Remains Sidelined on Express Scripts (ESRX) Following 2017 Guidance

December 14, 2016 1:16 PM EST

Mizuho Securities reiterated a Neutral rating and $76.00 price target on Express Scripts (NASDAQ: ESRX) following the company's initial 2017 guidance. 2017 adjusted EPS guidance is $6.82-$7.02, relatively in-line with consensus of $6.93 at the midpoint ($6.92), implies a +7-10% adjusted EPS growth y/y.

Analyst Ann Hynes commented,... More